Emmanuel Mahlis

Emmanuel Mahlis, MD has a diverse and extensive work experience in the medical field. Emmanuel is currently serving as the Vice President of Medical Affairs at MTF Biologics and is also the Principal at Mahlis Medical Consulting, LLC. In the past, they have held leadership positions at various pharmaceutical companies such as Acadia Pharmaceuticals Inc., DBV Technologies, Pfizer, OptiNose, and Alcon, A Novartis Division. Emmanuel has also served as a board member of the Asthma and Allergy Foundation of America. Prior to that, they worked as a healthcare consultant and held the position of Vice President and Head of US Medical Affairs at Celgene. Throughout their career, Emmanuel Mahlis, MD has been involved in strategic medical initiatives, launching new products, optimizing data generation programs, and leading medical teams.

Emmanuel Mahlis, MD completed their education in a chronological order. From 1980 to 1984, they attended Rutgers University - Newark and earned a Bachelor of Science (BS) degree in Chemistry. Following this, they enrolled at St. George's University from 1984 to 1989, where they obtained their MD degree in Medicine. Subsequently, from 1989 to 1992, they pursued an Internal Medicine Residency Program at Mountainside Hospital, specializing in Internal Medicine.

In addition to their education, Emmanuel Mahlis, MD has obtained two additional certifications. In 2023, they completed a Mini-MBA in Healthcare Management from Rutgers University–New Brunswick. Emmanuel also holds a certification as a Certified Dementia Practitioner from the National Council of Certified Dementia Practitioners, although the exact date of completion is not specified in the available information.